Back to previous section

Renalytix launches £500k retail offer

Clinical diagnostic solutions business Renalytix has launched a retail offer via the Winterflood Retail Access Platform to raise up to £500,000 through the issue of new ordinary shares at 9.5p apiece.

Renalytix

Source: Sharecast

The offer, which was open to existing UK shareholders and eligible investors, will run until 25 September and was conditional on the completion of a separate placing to raise a minimum of £4.0m, also at 9.5p per share. Both the placing and the WRAP offer are subject to admission to trading on AIM, expected to take effect on 29 September.

Renalytix said on Monday that the placing price represents an 11.6% discount to its closing mid-market price of 10.75p on 19 September, but a 39% premium to its 90-day average. It also said proceeds from both fundraises would be used in the same way, though no prospectus will be issued under the WRAP offer.

The AIM-listed firm added that the move reflected its commitment to retail shareholders and would allow broader participation in its capital raise. Investors must subscribe a minimum of £500 to take part, with shares ranking pari passu with existing stock.

As of 1125 BST, Renalytix shares were up 2.79% at 11.05p.

Reporting by Iain Gilbert at Sharecast.com

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

Lloyds Bank is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.

Important legal information

Lloyds and Lloyds Bank are trading names of Halifax Share Dealing Limited. The Lloyds Bank Direct Investments Service is operated by Halifax Share Dealing Limited. Registered Office: Trinity Road, Halifax, West Yorkshire, HX1 2RG. Registered in England and Wales no. 3195646. Halifax Share Dealing Limited is authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under registration number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

Logo Allfunds

The information contained within this website is provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd unless otherwise stated. The information is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. This is a solution powered by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd incorporating their prices, data news, charts, fundamentals and investor tools on this site. Terms and conditions apply. Prices and trades are provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd and are delayed by at least 15 minutes.

FE fundinfo Logo

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

Refinitiv Logo

© 2025 Refinitiv, an LSEG business. All rights reserved.